NCR1 and primary cutaneous T-cell non-Hodgkin lymphoma: Nevertheless, increased expression of NKp46 on CTCL skin NK cells could indicate that CTCL NK cells can still be activated to induce tumor killing, and NK cell stimulation ex vivo or locally in vivo could thus represent promising future possibilities for immunotherapy in CTCL.